Latest filing published 20 Nov 2018 for MPX Bioceutical Corporation, €136k.
Elizabeth M. Stavola is a declared insider of MPX Bioceutical Corporation, with filings sourced from SEDI. In total, 4 filings cover trades dated from 23 January 2017 to 16 November 2018.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 20 November 2018 with an option exercise (€136k) in MPX Bioceutical Corporation. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations